VOLIBRIS 5 MG Israel - English - Ministry of Health

volibris 5 mg

glaxo smith kline (israel) ltd - ambrisentan - film coated tablets - ambrisentan 5 mg - ambrisentan - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment with tadalafil.efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.

VOLIBRIS 10 MG Israel - English - Ministry of Health

volibris 10 mg

glaxo smith kline (israel) ltd - ambrisentan - film coated tablets - ambrisentan 10 mg - ambrisentan - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment with tadalafil.efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease.

BATRAFEN NAIL LACQUER Israel - English - Ministry of Health

batrafen nail lacquer

pharma shalom - ciclopirox - lacque - ciclopirox 80 mg/g - ciclopirox - ciclopirox - for the treatment of fungal infections of the nails.

REBETOL Israel - English - Ministry of Health

rebetol

merck sharp & dohme israel ltd - ribavirin - capsules - ribavirin 200 mg - ribavirin - ribavirin - tritherapy:rebetol in combination with boceprevir and peginterferon alfa-2b is indicated for the treatment of chronic hepatitis c (chc) genotype1 infection in adults patients (18 years of age and older) with compensated liver disease who are previously untreated or who have failed previous therapy.bitherapy:rebetol is indicated for the treatment of chronic hepatitis c virus infection in adults and must only be used as part of a combination regimen with peginterferon alfa-2b or interferon alfa-2b .rebetol monotherapy must not be used. there is no safety or efficacy information on the use of rebetol with other forms of interferon (i.e., not alfa-2b).previously untreated (naïve) patientsadult patients (18 years of age or older): rebetol is indicated for:• tritherapy- in combination with peginterferon alfa-2b and boceprevir for the treatment of adult patients with chronic hepatitis c genotype1 infection with compensated liver disease.• bitherapy- in combination with interferon alfa-2b or peginterferon alfa-2b, fo

OMR-IGG-AM 5 % Israel - English - Ministry of Health

omr-igg-am 5 %

omrix biopharmaceuticals - immunoglobulins, normal human - solution for infusion - immunoglobulins, normal human 50 mg/ml mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy * primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinemia or hypogammaglobulinemia) * myeloma or chronic lymphocytic leukemia (cll) with severe secondary hypogammaglobulinemia and recurrent infections. * children with congenital aids and recurrent infections - immunomodulation * idiopathic thrombocytopenic purpura (itp) * guillain barre syndrome * kawasaki disease - allogenic bone marrow transplantation

TASIGNA 200 MG Israel - English - Ministry of Health

tasigna 200 mg

novartis israel ltd - nilotinib as monohydrate - capsules - nilotinib as monohydrate 200 mg - nilotinib - nilotinib - treatment of philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) in chronic or accelerated phase in patients resistant to or experiencing significant toxicity during treatment with imatinib.treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

TASIGNA 150 MG Israel - English - Ministry of Health

tasigna 150 mg

novartis israel ltd - nilotinib as hydrochloride monohydrate - capsules - nilotinib as hydrochloride monohydrate 150 mg - nilotinib - nilotinib - treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

ANAGRID 0.5 Israel - English - Ministry of Health

anagrid 0.5

rafa laboratories ltd - anagrelide as hydrochloride - capsules - anagrelide as hydrochloride 0.5 mg - anagrelide - anagrelide - indicated for the treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.

DECAPEPTYL 0.1 Israel - English - Ministry of Health

decapeptyl 0.1

ferring pharmaceuticals ltd - triptorelin acetate - solution for injection - triptorelin acetate 0.1 mg/ml - triptorelin - triptorelin - ivf

CATAFLAM 50 MG Israel - English - Ministry of Health

cataflam 50 mg

novartis israel ltd - diclofenac as potassium - tablets - diclofenac as potassium 50 mg - diclofenac - diclofenac - management of pain and primary dysmenorrhea, when prompt pain relief is desired.